Straits Research Logo.png
Cancer and Allied Advancements in Chemotherapy – Straits Research
16 sept. 2021 09h00 HE | Straits Research
New York, US, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The chemotherapy market is expected to grow at a compound annual growth rate (CAGR) of 10.4% in the forecast period from 2020 to 2029. The global...
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
Nicosia, Cyprus, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and one of the world's largest producers of precious metals, Krastsvetmet (Russia, Krasnoyarsk), discussed...
AMR Logo.png
Oncology/Cancer Drugs Market to Reach $222.38 Bn by 2027 at 7.4% CAGR
20 avr. 2021 08h40 HE | Allied Market Research
Portland, OR, April 20, 2021 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Oncology/Cancer Drugs Market by Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy,...
Global PARP Inhibitor Market To Grow At A CAGR Of 27.4% Due To Expanding Role Of PARP Inhibitors In Cancer Treatment
22 juil. 2020 08h30 HE | Quince Market Insights
Pune, India, July 22, 2020 (GLOBE NEWSWIRE) -- Global PARP Inhibitor Market was valued at USD 924 million in 2018 and predicted to grow at an exponential CAGR of 27.4% during the forecast period....
Hausfeld logo
Celgene Rescinds Agreement to Compensate Cancer Patients Days Before Christmas
08 janv. 2020 13h36 HE | Hausfeld
WASHINGTON, Jan. 08, 2020 (GLOBE NEWSWIRE) -- On December 23, 2019, Celgene backed out of a settlement in which it had agreed to pay $55 million to end payors (consumers, insurers, union health and...
Rich Pharma logo.png
Rich Pharmaceuticals Retains Experienced Contact Research Organization to Assist with Clinical Trials
05 déc. 2017 10h35 HE | Rich Pharmaceuticals
BEVERLY HILLS, CA , Dec. 05, 2017 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA), a biopharmaceutical Company focused on developing and commercializing innovative therapies in...
Potential Future Sales of Nuvilex, Inc. Cancer Treatments Make Investment in Cell-in-a-Box Worth It
26 mars 2013 08h30 HE | Nuvilex, Inc.
NEW YORK, NY--(Marketwire - Mar 26, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is a small biotechnology company out of Silver Spring, Maryland, but its future might be anything but small. As the company...
A Tale of Two Biotech Companies: Q&A With Roche (SIX: RO, ROG; OTCQX: RHHBY) and Sunshine Biopharma (OTCBB: SBFM) Discussing Lead Cancer Products
16 juil. 2012 08h30 HE |; Roche; Sunshine Biopharma Inc.
NEW YORK, NY--(Marketwire - Jul 16, 2012) -, an investor research portal specializing in sector research including biotech and pharma stocks, issues a Q&A snapshot of two...